Covid-19 created many attractive opportunities for Novo Holdings in 2020

Even though Covid-19 caused a volatile market situation in 2020, the overall tailwind for the life science sector has also boosted Novo Holdings' life science investment portfolio, states CEO Kasim Kutay.

Novo Holdings Kasim Kutay CEO | Photo: Novo Holdings / PR

The markets were in the middle of a heavy dive last year in March, when Novo Holdings presented its annual report. However, the holding and investment company saw major potential in this dive, and far along the way, the potential has been realized, Novo Holdings CEO tells Kasim Kutay.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs